Average first day pops ranged from -41% to +41% as nine deals raised a combined $2.1 billion this week. High-end software provider Altair was the top performer, returning 41% on its market debut, as investors valued its sticky...read more
Spero Therapeutics, which is developing treatments for drug-resistant bacterial infections, raised $77 million by offering 5.5 million shares at $14, the low end of the range of $14 to $16. It had previously filed to offer 5.0 million shares. Insiders indicated...read more
The IPO market's active fourth quarter continues with another busy week. As many as nine IPOs plan to raise $2.1 billion. This week features three growth IPOs, all with positive operating income: toy maker Funko (FNKO), chip producer...read more
Spero Therapeutics, which is developing antibiotics for drug-resistant bacterial infections, announced terms for its IPO on Monday. The Cambridge, MA-based company plans to raise $75 million by offering 5 million shares at a price range of $14 to $16....read more
US IPO Weekly Recap: No Pop! for Funko in 9 IPO week
Average first day pops ranged from -41% to +41% as nine deals raised a combined $2.1 billion this week. High-end software provider Altair was the top performer, returning 41% on its market debut, as investors valued its sticky...read more
Antibiotic biotech Spero Therapeutics prices IPO at $14 low end
Spero Therapeutics, which is developing treatments for drug-resistant bacterial infections, raised $77 million by offering 5.5 million shares at $14, the low end of the range of $14 to $16. It had previously filed to offer 5.0 million shares. Insiders indicated...read more
US IPO Week Ahead: Bobbleheads, biotechs, software and more in a 9-IPO week
The IPO market's active fourth quarter continues with another busy week. As many as nine IPOs plan to raise $2.1 billion. This week features three growth IPOs, all with positive operating income: toy maker Funko (FNKO), chip producer...read more
Antibiotic biotech Spero Therapeutics sets terms for $75 million IPO
Spero Therapeutics, which is developing antibiotics for drug-resistant bacterial infections, announced terms for its IPO on Monday. The Cambridge, MA-based company plans to raise $75 million by offering 5 million shares at a price range of $14 to $16....read more